Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000227744

Medchemexpress LLC EGFR-IN-17 100mg | 2817679-31-3 | 568.01 g/mol | C27H31ClN7O3P | 100 MG
SDP

Catalog No. 5000227744
Encompass_Preferred

EGFR-IN-17 is a potent, selective small-molecule inhibitor of the epidermal growth factor receptor (EGFR) developed to overcome C797S-mediated resistance. It exhibits sub-nanomolar biochemical potency against mutant EGFR and is supplied as a high-purity solid for in vitro research use.

  • Sub-nanomolar potency against mutant EGFR (reported IC50 0.0002 μM).
  • Active against C797S/T790M/L858R EGFR mutants.
  • High purity (≈98.2%) solid for laboratory use.
  • Soluble in DMSO; sonication or warming may improve solubility.
  • Multiple package sizes available for small-scale research.
  • Storage recommendations provided for powder and solution formats.

Catalog No. 50-002-27744 Supplier Medchemexpress LLC Supplier No. HY115716100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

EGFR-IN-17 is a potent, selective small-molecule inhibitor of the epidermal growth factor receptor (EGFR) developed to overcome C797S-mediated resistance. It exhibits sub-nanomolar biochemical potency against mutant EGFR and is supplied as a high-purity solid for in vitro research use.

  • Sub-nanomolar potency against mutant EGFR (reported IC50 0.0002 μM).
  • Active against C797S/T790M/L858R EGFR mutants.
  • High purity (≈98.2%) solid for laboratory use.
  • Soluble in DMSO; sonication or warming may improve solubility.
  • Multiple package sizes available for small-scale research.
  • Storage recommendations provided for powder and solution formats.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.